The global animal health market size attained a value of approximately USD 59.24 Billion in 2024 . The market is further expected to grow in the forecast period of 2025-2034 at a CAGR of 6.40 %, reaching a value of around USD 110.16 Billion by 2034 .
Meanwhile, the Asia Pacific animal healthcare market is anticipated to experience rapid growth in the coming years, fuelled by increasing initiatives for animal welfare, rising pet ownership, and investments towards veterinary infrastructure. Major players are broadening their presence in the Asia Pacific to tap into the growing market for animal health industry.
The human and companion animal bond is increasing, strengthening the market for related products such as animal food and medicine. The animal health market is also likely to be driven by increasing pet ownership in developing nations, rising spending on pets, and increasing demand for novel premium treatments and medicines. Key therapeutic sectors for companion animals such as dogs and cats include endocrinology, dermatology, analgesia and anaesthesia, antibiotics, cardiovascular, and critical care. One of the primary objectives of animal health market research is to identify growth opportunities within the sector.
Drivers of the commercial animals segment in the market for animal health include rise in demand for high quality animal protein and dairy products. The growing focus on commercial animal welfare, increasing demand for more healthy and productive animals, and greater vaccine use, are further catalysing animal health market growth. Key therapeutic sectors for commercial animals such as swine, poultry, and cattle include water soluble antibiotics, vaccines, and locomotion (lameness) and pain management.
Development of efficient vaccines to protect a greater number of animals against illnesses and decrease the risk of spread of zoonotic diseases from animals to humans is a key focus area in the market for animal health. Further scope for market expansion include alternatives to antibiotics to minimise antimicrobial resistance and damage to the environment and development of digital technologies for early recognition of diseases. Discovering efficient methods of parasite control to improve animal health and reduce damage on the environment from parasiticide usage is another priority in the market.
Animal Health Market Share by Region
At a regional level, the North America animal healthcare market occupies a sizable share of the global market for animal health. This can be attributed to the high rates of pet ownership, widespread veterinary network, extensive demand for animal-based products, and rising awareness among pet and commercial animal owners regarding animal welfare. Governments in the region and animal welfare organisations also strive to enhance animal health in the region. The US animal health market size is expanding, supported by increasing demand for commercial animals, rising prevalence of zoonotic diseases, and growing spending of pet owners towards companion animals.Meanwhile, the Asia Pacific animal healthcare market is anticipated to experience rapid growth in the coming years, fuelled by increasing initiatives for animal welfare, rising pet ownership, and investments towards veterinary infrastructure. Major players are broadening their presence in the Asia Pacific to tap into the growing market for animal health industry.
Rising Pet Ownership and Greater Demand for Animal Welfare to Augment the Market
The global market for animal health is expected to be driven by increasing pet ownership and demand for animal healthcare commodities, especially nutrition, vaccines, and medicines. The global companion animal healthcare market size is projected to grow owing to the increasingly strengthening owner and companion animal bond which escalates the demand for companion animal care products. Companion animals, such as cats, dogs, and horses form an important part of life for several people, offering companionship, feeling of responsibility, and affection. Animal-assisted therapy has been recognised and widely accepted due to its benefits.The human and companion animal bond is increasing, strengthening the market for related products such as animal food and medicine. The animal health market is also likely to be driven by increasing pet ownership in developing nations, rising spending on pets, and increasing demand for novel premium treatments and medicines. Key therapeutic sectors for companion animals such as dogs and cats include endocrinology, dermatology, analgesia and anaesthesia, antibiotics, cardiovascular, and critical care. One of the primary objectives of animal health market research is to identify growth opportunities within the sector.
Drivers of the commercial animals segment in the market for animal health include rise in demand for high quality animal protein and dairy products. The growing focus on commercial animal welfare, increasing demand for more healthy and productive animals, and greater vaccine use, are further catalysing animal health market growth. Key therapeutic sectors for commercial animals such as swine, poultry, and cattle include water soluble antibiotics, vaccines, and locomotion (lameness) and pain management.
Animal Health Market Analysis
One of the primary factors favourably affecting the global animal health market is the rising prevalence of zoonotic diseases, such as animal flu, tick infestation, and Lyme disease. The demand for adequate animal health is being driven by the growing trend of people getting companion animals as pets, which is leading to the rise of animal-borne illnesses.Development of efficient vaccines to protect a greater number of animals against illnesses and decrease the risk of spread of zoonotic diseases from animals to humans is a key focus area in the market for animal health. Further scope for market expansion include alternatives to antibiotics to minimise antimicrobial resistance and damage to the environment and development of digital technologies for early recognition of diseases. Discovering efficient methods of parasite control to improve animal health and reduce damage on the environment from parasiticide usage is another priority in the market.
Animal Health Industry Segmentation
Animal health refers to the products and processes involved in maintaining the health and well-being of animals, including commercial animals raised for meat and companion animals in the form of pets. Through animal health, owners can improve and maintain the health of their animals, using proper nutrition, feed additives, vaccines, diagnostics, and pharmaceuticals.By animal type, the market is segmented into:
- Commercial Animals
- Breakup by Type Poultry Swine Cattle Sheep and Goat Others
- Companion Animals
- Breakup by Type Dogs Cats Others
By product type, the market is divided into:
- Vaccines
- Pharmaceuticals
- Feed Additives
- Diagnostics
- Others
By end use, the market is classified into:
- Veterinary Hospitals and Clinics
- Animal Care and Rehabilitation Centres
- Diagnostics Centres
- Others
By region, the market is segmented into:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Key Players in the Global Animal Health Market
The report presents a detailed analysis of the following key players in the market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:- Elanco Animal Health Incorporated
- Merck Animal Health
- Zoetis Inc.
- Biogenesis Bago
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Heska Corporation
- IDEXX Laboratories, Inc.
- Virbac S.A.
- Vetoquinol SA
- Others
Table of Contents
1 Executive Summary
2 Market Overview and Stakeholder Insights
3 Economic Summary
4 Country Risk Profiles
5 Global Animal Health Market Analysis
6 North America Animal Health Market Analysis
7 Europe Animal Health Market Analysis
8 Asia Pacific Animal Health Market Analysis
9 Latin America Animal Health Market Analysis
10 Middle East and Africa Animal Health Market Analysis
11 Market Dynamics
12 Competitive Landscape
Companies Mentioned
- Elanco Animal Health Incorporated
- Merck Animal Health
- Zoetis Inc.
- Biogenesis Bago
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Heska Corporation
- IDEXX Laboratories, Inc.
- Virbac S.A.
- Vetoquinol SA
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 179 |
Published | July 2025 |
Regions Covered | Global |
No. of Companies Mentioned | 10 |